Two Sigma Investments, LP Gossamer Bio, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 891,279 shares of GOSS stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

891,279

Previous 630,961 41.26%

Holding current value

$1.17 Million

Previous $624,000 28.53%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.66 - $1.07 $171,809 - $278,540	260,318 Added 41.26%	891,279 $802,000
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $253,575 - $401,227	320,982 Added 103.55%	630,961 $624,000
Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $254,383 - $633,465	-498,792 Reduced 61.67%	309,979 $278,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $170,792 - $322,369	-213,490 Reduced 20.88%	808,771 $954,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $233,359 - $525,059	486,166 Added 90.69%	1,022,261 $930,000
Q3 2023 Nov 14, 2023	SELL	$0.78 - $1.82 $805,952 - $1.88 Million	-1,033,273 Reduced 65.84%	536,095 $444,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $299,831 - $468,105	-305,951 Reduced 16.31%	1,569,368 $1.88 Million
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $395,711 - $1.2 Million	412,199 Added 28.17%	1,875,319 $2.36 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $935,063 - $6.92 Million	537,393 Added 58.05%	1,463,120 $3.17 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $4.9 Million - $10.1 Million	680,167 Added 276.99%	925,727 $11.1 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $1.21 Million - $2.03 Million	-203,497 Reduced 45.32%	245,560 $2.06 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $985,842 - $1.46 Million	116,806 Added 35.16%	449,057 $3.9 Million
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $1.45 Million - $2.01 Million	142,891 Added 75.46%	332,251 $3.76 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $2.09 Million - $3.82 Million	-288,700 Reduced 60.39%	189,360 $2.38 Million
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $1.76 Million - $2.15 Million	-220,015 Reduced 31.52%	478,060 $3.88 Million
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $4.57 Million - $5.79 Million	529,220 Added 313.42%	698,075 $6.46 Million
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $1.57 Million - $2.56 Million	-188,708 Reduced 52.78%	168,855 $1.63 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $729,347 - $952,024	64,544 Added 22.03%	357,563 $4.44 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $2.53 Million - $4.24 Million	265,553 Added 966.84%	293,019 $3.81 Million
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $219,728 - $425,173	27,466 New	27,466 $279,000

Others Institutions Holding GOSS

# of Institutions

116

Shares Held

153M

Call Options Held

793K

Put Options Held

528K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $123M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Gossamer Bio, Inc. Transaction History